Literature DB >> 16259105

The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors.

Anna-Mária Tokés1, Janina Kulka, Sándor Paku, Miklós Máthé, Csilla Páska, Csaba Lódi, András Kiss, Zsuzsa Schaff.   

Abstract

The evaluation of the role of claudins (CLDNs) in breast carcinogenesis has recently begun. We investigated the expression of CLDNs 1, 2, 3, 4, and 7 in pT1pN0 and pT1pN1 invasive ductal breast carcinomas. Tissue arrays of 30-30 pT1pN0 and pT1pN1 invasive ductal breast carcinomas of different grades were constructed, and the expression of CLDN 1, 2, 3, 4, and 7 proteins was analyzed using standard and immunofluorescent immunohistochemistry. The results were evaluated by light and confocal microscopy. Regarding CLDN 1, 4, and 7 expressions, differences were noted between normal and tumor cells and also between tumors of different grades, while no remarkable differences were noted between pT1pN0 and pT1pN1 tumors. CLDNs 1 and 7 were found to be downregulated in tumor cells compared to the normal epithelium, while CLDN 4 expression was decreased in grade 1 tumors. CLDN 7 protein was abundant in normal epithelia, and the staining decreased in grade 3 tumors. There were no differences between normal and neoplastic cells regarding CLDN 2 and 3 expressions. As a preliminary result, our observations suggest that the analyzed CLDNs do not promote tumor metastasis. On the basis of our findings, it seems that CLDN 1, CLDN 4, and CLDN 7 may rather have an important role in tumorigenesis or in cell-to-cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259105     DOI: 10.1016/j.prp.2005.05.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

1.  Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines.

Authors:  Maria C Todd; Heather M Petty; Jonathan M King; Brytanie N Piana Marshall; Rebecca A Sheller; Maria E Cuevas
Journal:  Oncol Lett       Date:  2015-04-28       Impact factor: 2.967

2.  Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer.

Authors:  Kyung Won Seo; Young Kee Kwon; Byung Hoon Kim; Chun Il Kim; Hyuk Soo Chang; Mi Sun Choe; Choal Hee Park
Journal:  Korean J Urol       Date:  2010-04-20

3.  Expression of tight junction protein claudin-4 in basal-like breast carcinomas.

Authors:  Janina Kulka; Attila Marcell Szász; Zsuzsanna Németh; Lilla Madaras; Zsuzsa Schaff; István Arthur Molnár; Anna-Mária Tokés
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

4.  Increased expression of claudin-1 and claudin-7 in liver cirrhosis and hepatocellular carcinoma.

Authors:  Ágnes Holczbauer; Benedek Gyöngyösi; Gábor Lotz; Péter Törzsök; Pál Kaposi-Novák; Attila Szijártó; Péter Tátrai; Péter Kupcsulik; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2014-04-03       Impact factor: 3.201

5.  The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.

Authors:  Jette Bornholdt; Stine Friis; Sine Godiksen; Steen S Poulsen; Eric Santoni-Rugiu; Hanne C Bisgaard; Inger M B Lothe; Tone Ikdahl; Kjell M Tveit; Egil Johnson; Elin H Kure; Lotte K Vogel
Journal:  BMC Cancer       Date:  2011-02-10       Impact factor: 4.430

6.  Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer.

Authors:  Mehmet Karabulut; Halil Alis; Koray Bas; Senem Karabulut; Cigdem Usul Afsar; Hilal Oguz; Meral Gunaldi; Cevher Akarsu; Osman Kones; Nuri Faruk Aykan
Journal:  Mol Clin Oncol       Date:  2015-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.